Aggravation of myasthenia gravis by erythromycin

8 October 1990

journal article
research article
Published by Wiley in Annals of Neurology

Vol. 28 (4) , 577-579
https://doi.org/10.1002/ana.410280417

Abstract

Erythromycin is not currently recognized as causing clinical aggravation of myasthenia gravis. We report the case of a patient who experienced exacerbations of myasthenia gravis subsequent to each of several doses of intravenous erythromycin. We suggest that erythromycin can cause clinical worsening in patients with disease of the neuromuscular junction.

This publication has 11 references indexed in Scilit:

The Neurotoxicity of Antibacterial Agents
Annals of Internal Medicine, 1984
Drugs that may exacerbate myasthenia gravis
Annals of Emergency Medicine, 1984
Effect of Low-Dose Propantheline on Food-Stimulated Gastric Acid Secretion
New England Journal of Medicine, 1977
Characterization of the neuromuscular block produced by clindamycin and lincomycin
Canadian Journal of Physiology and Pharmacology, 1976
The site of the neuromuscular block produced by polymyxin B and rolitetracycline
Canadian Journal of Physiology and Pharmacology, 1976
Clindamycin Enhances a Nondepolarizing Neuromuscular Blockade
Anesthesiology, 1976
The Electromyographic Changes Induced by Antibiotics
Stereotactic and Functional Neurosurgery, 1971
Myasthenic Syndrome Associated With Antibiotics
Archives of Neurology, 1968
The effect of lincomycin on neuromuscular transmission
Toxicology and Applied Pharmacology, 1968
Neuromuscular blocking properties of various antibiotic agents
Toxicology and Applied Pharmacology, 1959